Publicacións en colaboración con investigadores/as de Universidade de Santiago de Compostela (20)

2024

  1. Versatile hybrid technique for passive straight micromixer manufacturing by combining pulsed laser ablation, stereolithographic 3D printing and computational fluid dynamics

    Lab on a Chip, Vol. 24, Núm. 10, pp. 2669-2682

2023

  1. Wastewater early warning system for SARS-CoV-2 outbreaks and variants in a Coruña, Spain

    Environmental Science and Pollution Research, Vol. 30, Núm. 32, pp. 79315-79334

2022

  1. Modeling the number of people infected with SARS-COV-2 from wastewater viral load in Northwest Spain

    Science of the Total Environment, Vol. 811

2021

  1. Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDR Pseudomonas aeruginosa infections

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 1, pp. 91-100

  2. Rapid evolutionary turnover of mobile genetic elements drives bacterial resistance to phages

    Science, Vol. 374, Núm. 6566, pp. 488-492

2016

  1. Change of concept about the regulation of angiotensin II-induced monocyte chemoattractant protein-1 production in human endothelial cells

    Vascular Pharmacology, Vol. 80, pp. 20-34

2015

  1. Glycated human serum albumin induces NF-κB activation and endothelial nitric oxide synthase uncoupling in human umbilical vein endothelial cells

    Journal of Diabetes and its Complications, Vol. 29, Núm. 8, pp. 984-992

  2. Key structural and functional differences between early and advanced glycation products

    Journal of Molecular Endocrinology, Vol. 56, Núm. 1, pp. 23-37

2013

  1. Current status of NADPH oxidase researchin cardiovascular pharmacology

    Vascular Health and Risk Management, Vol. 9, Núm. 1, pp. 401-428

  2. Fluorescent Advanced Glycation End Products and Their Soluble Receptor: The Birth of New Plasmatic Biomarkers for Risk Stratification of Acute Coronary Syndrome

    PLoS ONE, Vol. 8, Núm. 9

  3. Statins modulate feedback regulation mechanisms between advanced glycation end-products and C-reactive protein: Evidence in patients with acute myocardial infarction

    European Journal of Pharmaceutical Sciences, Vol. 49, Núm. 4, pp. 512-518

2012

  1. Evidence for a role of advanced glycation end products in atrial fibrillation

    International Journal of Cardiology, Vol. 157, Núm. 3, pp. 397-402

  2. Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report

    Cardiovascular Diabetology, Vol. 11

  3. Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase

    Journal of Cellular Biochemistry, Vol. 113, Núm. 4, pp. 1386-1396

2011

  1. Productos de glicación avanzada: nuevo marcador de disfunción renal en pacientes con insuficiencia cardíaca crónica

    Medicina Clinica, Vol. 136, Núm. 12, pp. 513-521

  2. Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease

    European Journal of Endocrinology, Vol. 164, Núm. 4, pp. 529-537

  3. Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of seattle heart failure score

    American Journal of Cardiology, Vol. 107, Núm. 6, pp. 938-944

2010

  1. Glycated albumin, a precursor of advanced glycation end-products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: Molecular correlate of diabetic vasculopathy

    Diabetes/Metabolism Research and Reviews, Vol. 26, Núm. 7, pp. 550-558

  2. Pravastatin counteracts angiotensin II-induced upregulation and activation of nadph oxidase at plasma membrane of human endothelial cells

    Journal of Cardiovascular Pharmacology, Vol. 55, Núm. 2, pp. 203-212

  3. Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels

    European Journal of Heart Failure, Vol. 12, Núm. 10, pp. 1092-1100